Low-Density Lipoprotein Lowering Does Not Improve Calf Muscle Perfusion, Energetics, or Exercise Performance in Peripheral Arterial Disease
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baselineAtherosclerosis, 2011
- Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery diseaseVascular Medicine, 2010
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media ThicknessNew England Journal of Medicine, 2009
- Multifactorial Determinants of Functional Capacity in Peripheral Arterial DiseaseJACC, 2009
- Medication Underuse During Long-Term Follow-Up in Patients With Peripheral Arterial DiseaseCirculation: Cardiovascular Quality and Outcomes, 2009
- Skeletal Muscle Microvascular Flow in Progressive Peripheral Artery DiseaseJACC, 2009
- Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 DiabetesJACC, 2008
- Calf muscle perfusion at peak exercise in peripheral arterial disease: Measurement by first‐pass contrast‐enhanced magnetic resonance imagingJournal of Magnetic Resonance Imaging, 2007
- Delayed Calf Muscle Phosphocreatine Recovery After Exercise Identifies Peripheral Arterial DiseaseJACC, 2006
- Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drugThe American Journal of Cardiology, 2002